Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI

Stroke

Volumn 31, Issue 6, 2000, Pages 1318-1328

  Schellinger, Peter D ^a   Jansen, Olav ^a   Fiebach, Jochen B ^a   Heiland, Sabine ^a   Steiner, Thorsten ^a   Schwab, Stefan ^a   Pohlers, Olivia ^a   Ryssel, Henning ^a   Sartor, Klaus ^a   Hacke, Werner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Diffusion weighted; Magnetic resonance imaging; Perfusion weighted; Recanalization; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BLOOD VESSEL OCCLUSION; BRAIN ISCHEMIA; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RECANALIZATION; RISK ASSESSMENT;

EID: 0034035399     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.6.1318     Document Type: Article

References (43)

1. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998; 352:1245-1251.
2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoexter G, Mahagne MH, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study. JAMA. 1995;274:1017-1025.
3. The National Institute of Neurological Disorders, and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
4. 3a.Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282: 2019-2026.
5. Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marier JR, Levine SR, Broderick JP, Kwiatkowski TG, Frankel M, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke: NINDS rt-PA Stroke Study Group. Neurology. 1998;50:883-890.
6. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 1996;16: 53-59.
7. Warach S, Boska M, Welch KM. Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke. Stroke. 1997;28: 481-482.
8. Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang Hellinger FR, Reese TG, Weisskoff RM, Davis TL, Suwanwela N, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology. 1996;199:391-401.
9. Tong DC, Yenari MA, Albers GW, M OB, Marks MP, Moseley ME. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology. 1998;50:864-870.
10. Moseley ME, Wendland MF, Kucharczyk J. Magnetic resonance imaging of diffusion and perfusion. Top Magn Reson imaging. 1991;3:50-67.
11. Mintorovitch J, Moseley ME, Chileuitt L, Shimizu H, Cohen Y, Weinstein PR. Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med. 1991;18:39-50.
12. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology. 1998;51: 418-426.
13. Bahn MM, Oser AB, Cross DT III. CT and MRI of stroke. J Magn Reson Imaging. 1996;6:833-845.
14. Jansen O, Schellinger PD, Fiebach JB, Hacke W, Sartor K. Early recanalization in acute ischemic stroke saves tissue at risk defined by MRI. Lancet. 1999;353:2036-2037.
15. Lovblad KO, Baird AE, Schlaug G, Benfield A, Siewert B, Voetsch B, Connor A, Burzynski C, Edelman RR, Warach S. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol. 1997;42:164-170.
16. Marks MP, Tong D, Beaulieu C, Albers G, de Crespigny A, Moseley ME. Evaluation of early reperfusion and IV rt-PA therapy using diffusion- and perfusion-weighted MRI. Neurology. 1999;52:1792-1798.
17. Heiland S, Benner T, Reith W, Forsting M, Sartor K. Perfusion-weighted MRI using gadobutrol as a contrast agent in a rat stroke model. J Magn Reson Imaging. 1997;7:1109-1115.
18. Rempp KA, Brix G, Wenz F, Becker CR, Gückel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology. 1994;193: 637-641.
19. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke. Stroke. 1985;16:885-890.
20. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md Med J. 1965;21-23:61-65.
21. Rankin J. Cerebral vascular accidents in people over the age of 60: prognosis. Scott Med J. 1957;2:200-215.
22. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler I. Improved reliability of the NIH Stroke Scale using video training: NINDS TPA Stroke Study Group. Stroke. 1994;25: 2220-2226.
23. Koroshetz WJ, Gonzalez G. Diffusion-weighted MRI: an ECG for 'brain attack'? Ann Neurol. 1997;41:565-566.
24. Powers WJ, Zivin J. Magnetic resonance imaging in acute stroke: not ready for prime time. Neurology. 1998;50:842-843.
25. Deleted in proof.
26. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
27. Conturo TE, McKinstry RC, Aronovitz JA, Neil JJ. Diffusion MRI: precision, accuracy and flow effects. NMR Biomed. 1995;8:307-332.
28. Moseley M. Pathophysiologic basis of diffusion and perfusion-weighted imaging. In: 25th International Stroke Conference; February 10-12, 2000; New Orleans, La.
29. Ginsberg MD, Pulsinelli WA. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann Neurol. 1994;36:553-554.
30. Jansen O, Heiland S, Schellinger P. Neuroradiological diagnosis in acute ischemic stroke: value of modern techniques. Nervenarzt. 1998;69:465-471.
31. Schellinger PD, Jansen O, Fiebach JB, Hacke W, Sartor K. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke. 1999;30:765-768.
32. Busch E, Beaulieu C, de Crespigny A, Moseley ME. Diffusion MR imaging during acute subarachnoid hemorrhage in rats. Stroke. 1998;29: 2155-2161.
33. Wiesmann M, Mayer TE, Medele R, Brueckmann H. Diagnosis of acute subarachnoid hemorrhage at 1.5 Tesla using proton-density weighted FSE and MRI sequences. Radiologe. 1999;39:860-865.
34. von Kummer R, Holle R, Rosin L, Forsting M, Hacke W. Does arterial recanalization improve outcome in carotid territory stroke? Stroke. 1995; 26:581-587.
35. Mon E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology. 1992;42: 976-982.
36. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology. 1993;35: 159-162.
37. Rordorf G, Koroshetz WJ, Copen WA, Cramer SC, Schaefer PW, Budzik RF Jr, Schwamm LH, Buonanno F, Sorensen AG, Gonzalez G. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke. 1998;29:939-943.
38. von Kummer R, Berrouschot J, Barthel H, Hesse S, Dieler C, Schneider D. The effect of early and late brain tissue reperfusion on infarct volume. Stroke. 2000;31:275. Abstract.
39. Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke. 1999;30:287-292.
40. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309-315.
41. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke. 1998;29:2461-2466.
42. Schwab S, Rieke K, Krieger D, Hund E, Aschoff A, von Kummer R, Hacke W. Craniectomy in space-occupying middle cerebral artery infarcts. Nervenarzt. 1995;66:430-437.
43. Schwab S, Steiner T, Aschoff A, Schwarz S. Steiner HH, Jansen O, Hacke W. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998;29:1888-1893.